Search Result "FirstGeneration Antipsychotics"
Antipsychotics Management in Addictive Disorders
Journal: Current Psychopharmacology
Volume: 2 Issue: 3 Year: 2013 Page: 212-217
Author(s): Pierre Alexis Geoffroy,Benjamin Rolland,Vincent Laprevote,Olivier Cottencin
Naturalistic Studies of Second Generation Antipsychotics in the Treatment of Schizophrenia
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2004 Page: 329-342
Author(s): C. Simon Sebastian, William Glazer, Peter F. Buckley
Antipsychotic Use in Parkinson`s Disease
Ebook: Psychopharmacological Issues in Geriatrics
Volume: 1 Year: 2015
Author(s): Saioa Domingo-Echaburu
Doi: 10.2174/9781681080345115010015
Association between Serum Lipids and Antipsychotic Response in Schizophrenia
Journal: Current Neuropharmacology
Volume: 17 Issue: 9 Year: 2019 Page: 852-860
Author(s): David D. Kim,Alasdair M. Barr,Diane H. Fredrikson,William G. Honer,Ric M. Procyshyn
Cardio-Vascular Risks Associated with Clozapine Treatment
Journal: Current Psychiatry Reviews
Volume: 7 Issue: 3 Year: 2011 Page: 170-176
Author(s): Carlo Rostagno, Francesca Pastorelli, Sandro Domenichetti, Gian Franco Gensini
Prevalence, Severity and Characteristics of Tardive Dyskinesia Among Schizophrenia Patients in an Israeli Psychiatric Center
Journal: Current Psychopharmacology
Volume: 3 Issue: 1 Year: 2014 Page: 79-85
Author(s): Rony Sabbag,Bitya Fridman,Uriel Heresco-Levy
Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 8 Year: 2017 Page: 885-890
Author(s): Giovanni Amodeo,Andrea Fagiolini,Gabriele Sachs,Andreas Erfurth
The Associations between Central Nervous System Diseases and Haemostatic Disorders
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18 Issue: 4 Year: 2019 Page: 307-316
Author(s): Maria Podsiedlik,Magdalena Markowicz-Piasecka,Elżbieta Mikiciuk-Olasik,Joanna Sikora
Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1 Issue: 2 Year: 2002 Page: 141-147
Author(s): C. A. Tamminga, A. Carlsson
Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3771-3787
Author(s): Philipp Singer,Sylvain Dubroqua,Benjamin K. Yee